April 30, 2010 [Taoyuan, Taiwan]:

SHL just launched an improved website which has been designed to ensure that visitors can learn more about the extensive range of services offered by the company. The launch of the website coincides with the use of a new URL: www.shl-group.com

The website has been given a new look and is now easier to navigate. It highlights the capabilities and services that are offered by SHL, in particular those needed to mass produce auto-injectors, pen-injectors and inhalers for the pharmaceutical and biotech industry. The company's product section now focuses on select products that are on the market and also some SHL designed products that will soon be available.

Along with enhanced navigation and usability, the new website offers each visitor access to updates in connection with social media tools. RSS feeds are also available to keep our customers updated with the latest news and announcements from SHL. Our search function has also been enhanced to ensure that visitors can find the information that they need.

Steven R. Kaufman, the SHL Group Marketing Director, commented on the launch: "Not only will the new website provide more content, it is very visual with more interactive features. It’s not always possible for potential customers to visit our manufacturing faculties. By making the site more visual and interactive we can almost give visitors a virtual tour of our operations. In the coming months we will add significantly to the new website with more pictures and video, in addition to making frequent announcements. Communicating more directly to current and future customers is vital and our user friendly website is a step in the right direction."

We hope you enjoy our fresh look and updates. Your feedback would be greatly appreciated.

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of three distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

For additional information visit www.shl-group.com or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it